136 related articles for article (PubMed ID: 16432052)
1. Imatinib attenuates end-organ damage in hypertensive homozygous TGR(mRen2)27 rats.
Schellings MW; Baumann M; van Leeuwen RE; Duisters RF; Janssen SH; Schroen B; Peutz-Kootstra CJ; Heymans S; Pinto YM
Hypertension; 2006 Mar; 47(3):467-74. PubMed ID: 16432052
[TBL] [Abstract][Full Text] [Related]
2. Imatinib mesylate attenuates myocardial remodeling through inhibition of platelet-derived growth factor and transforming growth factor activation in a rat model of hypertension.
Jang SW; Ihm SH; Choo EH; Kim OR; Chang K; Park CS; Kim HY; Seung KB
Hypertension; 2014 Jun; 63(6):1228-34. PubMed ID: 24591339
[TBL] [Abstract][Full Text] [Related]
3. Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27.
de Boer RA; Pokharel S; Flesch M; van Kampen DA; Suurmeijer AJ; Boomsma F; van Gilst WH; van Veldhuisen DJ; Pinto YM
J Mol Med (Berl); 2004 Oct; 82(10):678-87. PubMed ID: 15322702
[TBL] [Abstract][Full Text] [Related]
4. Specific MAP-kinase blockade protects against renal damage in homozygous TGR(mRen2)27 rats.
de Borst MH; Navis G; de Boer RA; Huitema S; Vis LM; van Gilst WH; van Goor H
Lab Invest; 2003 Dec; 83(12):1761-70. PubMed ID: 14691294
[TBL] [Abstract][Full Text] [Related]
5. Effects of angiotensin II subtype 1 receptor blockade on cardiac fibrosis and sarcoplasmic reticulum Ca2+ handling in hypertensive transgenic rats overexpressing the Ren2 gene.
Rothermund L; Pinto YM; Vetter R; Herfort N; Kossmehl P; Neumayer HH; Paul M; Kreutz R
J Hypertens; 2001 Aug; 19(8):1465-72. PubMed ID: 11518855
[TBL] [Abstract][Full Text] [Related]
6. Imatinib attenuates myocardial fibrosis in association with inhibition of the PDGFRα activity.
Ma LK; Li Q; He LF; Hua JS; Zhou JL; Yu H; Feng KF; Chen HW; Hu H; Wang L
Arq Bras Cardiol; 2012 Dec; 99(6):1082-91. PubMed ID: 23184075
[TBL] [Abstract][Full Text] [Related]
7. Combined tyrosine and serine/threonine kinase inhibition by sorafenib prevents progression of experimental pulmonary hypertension and myocardial remodeling.
Klein M; Schermuly RT; Ellinghaus P; Milting H; Riedl B; Nikolova S; Pullamsetti SS; Weissmann N; Dony E; Savai R; Ghofrani HA; Grimminger F; Busch AE; Schäfer S
Circulation; 2008 Nov; 118(20):2081-90. PubMed ID: 18955668
[TBL] [Abstract][Full Text] [Related]
8. Early onset of chondroitin sulfate and osteopontin expression in angiotensin II-dependent left ventricular hypertrophy.
Rothermund L; Kreutz R; Kossmehl P; Fredersdorf S; Shakibaei M; Schulze-Tanzil G; Paul M; Grimm D
Am J Hypertens; 2002 Jul; 15(7 Pt 1):644-52. PubMed ID: 12118914
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological inhibition of galectin-3 protects against hypertensive nephropathy.
Frenay AR; Yu L; van der Velde AR; Vreeswijk-Baudoin I; López-Andrés N; van Goor H; Silljé HH; Ruifrok WP; de Boer RA
Am J Physiol Renal Physiol; 2015 Mar; 308(5):F500-9. PubMed ID: 25503732
[TBL] [Abstract][Full Text] [Related]
10. Salt loading exacerbates diastolic dysfunction and cardiac remodeling in young female Ren2 rats.
Whaley-Connell AT; Habibi J; Aroor A; Ma L; Hayden MR; Ferrario CM; Demarco VG; Sowers JR
Metabolism; 2013 Dec; 62(12):1761-71. PubMed ID: 24075738
[TBL] [Abstract][Full Text] [Related]
11. Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinase.
de Borst MH; van Timmeren MM; Vaidya VS; de Boer RA; van Dalen MB; Kramer AB; Schuurs TA; Bonventre JV; Navis G; van Goor H
Am J Physiol Renal Physiol; 2007 Jan; 292(1):F313-20. PubMed ID: 16896183
[TBL] [Abstract][Full Text] [Related]
12. Reduction in left ventricular messenger RNA for transforming growth factor beta(1) attenuates left ventricular fibrosis and improves survival without lowering blood pressure in the hypertensive TGR(mRen2)27 Rat.
Pinto YM; Pinto-Sietsma SJ; Philipp T; Engler S; Kossamehl P; Hocher B; Marquardt H; Sethmann S; Lauster R; Merker HJ; Paul M
Hypertension; 2000 Nov; 36(5):747-54. PubMed ID: 11082138
[TBL] [Abstract][Full Text] [Related]
13. Imatinib ameliorates renal morphological changes in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension.
Graciano ML; Mitchell KD
Am J Physiol Renal Physiol; 2012 Jan; 302(1):F60-9. PubMed ID: 21975872
[TBL] [Abstract][Full Text] [Related]
14. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
Bolbrinker J; Markovic S; Wehland M; Melenhorst WB; van Goor H; Kreutz R
J Pharmacol Exp Ther; 2006 Jan; 316(1):8-16. PubMed ID: 16166267
[TBL] [Abstract][Full Text] [Related]
15. Profiling of the renal kinome: a novel tool to identify protein kinases involved in angiotensin II-dependent hypertensive renal damage.
de Borst MH; Diks SH; Bolbrinker J; Schellings MW; van Dalen MB; Peppelenbosch MP; Kreutz R; Pinto YM; Navis G; van Goor H
Am J Physiol Renal Physiol; 2007 Jul; 293(1):F428-37. PubMed ID: 17429032
[TBL] [Abstract][Full Text] [Related]
16. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.
Stas S; Whaley-Connell A; Habibi J; Appesh L; Hayden MR; Karuparthi PR; Qazi M; Morris EM; Cooper SA; Link CD; Stump C; Hay M; Ferrario C; Sowers JR
Endocrinology; 2007 Aug; 148(8):3773-80. PubMed ID: 17494996
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 rat.
Whaley-Connell A; Govindarajan G; Habibi J; Hayden MR; Cooper SA; Wei Y; Ma L; Qazi M; Link D; Karuparthi PR; Stump C; Ferrario C; Sowers JR
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E355-63. PubMed ID: 17440033
[TBL] [Abstract][Full Text] [Related]
18. Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo.
Wang S; Wilkes MC; Leof EB; Hirschberg R
FASEB J; 2005 Jan; 19(1):1-11. PubMed ID: 15629889
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat.
Whaley-Connell AT; Chowdhury NA; Hayden MR; Stump CS; Habibi J; Wiedmeyer CE; Gallagher PE; Tallant EA; Cooper SA; Link CD; Ferrario C; Sowers JR
Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1308-14. PubMed ID: 16788142
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment.
Whaley-Connell A; Habibi J; Nistala R; Cooper SA; Karuparthi PR; Hayden MR; Rehmer N; DeMarco VG; Andresen BT; Wei Y; Ferrario C; Sowers JR
Hypertension; 2008 Feb; 51(2):474-80. PubMed ID: 18172055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
